These results demonstrate disease-free survival rates comparable to those reported for patients undergoing radical prostatectomy, an invasive surgical procedure. Importantly, these data provide OncoSeed with 10 years' more published clinical data than for any other iodine-125 seed.
Prostate cancer is the most common form of cancer in men.
According to the National Cancer Institute, more than 180,000 American men will be diagnosed with prostate cancer in 2000, and 35,000 men will die from the disease. An estimated 8 out of 10 men diagnosed with prostate cancer are over 65. Together, they comprise 957 health care facilities nationwide and are affiliated with more than 900 others. Premier provides hospitals and health care systems with products and services designed to maximize quality and safety, reduce unnecessary costs, manage technology, and promote a continuum of care. Understanding Brachytherapy Prostate brachytherapy, also referred to as seed implantation, is a minimally invasive outpatient procedure in which radioactive I-125 seeds are implanted within the prostate, where they irradiate the tumor.